Home/BiosanaPharma/Ard Tijsterman
AT

Ard Tijsterman

CEO

BiosanaPharma

BiosanaPharma Pipeline

DrugIndicationPhase
3C Platform Licensing & ImplementationBiologics Manufacturing TechnologyCommercial
Omalizumab Biosimilar (with Alvotech)Not Specified (Biosimilar)Development